Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GOSS will decline by -54.86% over the next 2 Weeks and hit $0.19 by Tuesday, March 10, 2026. In that time frame, GOSS's share price is expected to range between $0.07 and $0.31.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 10, 2026 | 0.07 | 0.19 | 0.31 |
| Mar 9, 2026 | 0.06 | 0.19 | 0.32 |
| Mar 6, 2026 | 0.03 | 0.14 | 0.27 |
| Mar 5, 2026 | 0.09 | 0.21 | 0.33 |
| Mar 4, 2026 | 0.13 | 0.24 | 0.36 |
| Mar 3, 2026 | 0.18 | 0.30 | 0.42 |
| Mar 2, 2026 | 0.18 | 0.30 | 0.42 |
| Feb 27, 2026 | 0.14 | 0.26 | 0.37 |
| Feb 26, 2026 | 0.21 | 0.33 | 0.45 |
| Feb 25, 2026 | 0.24 | 0.36 | 0.47 |
GOSS shares fell -8.50% in Wednesday, February 25, 2026's trading session, dropping from a previous close of $0.42 to move at $0.38. The stock demonstrated notable intraday movement (see GOSS's key stats for a full breakdown), fluctuating between $0.33 and $0.40, a +20.95% trading range. While recent weeks have seen some volatility, GOSS has managed to secure a -83.83% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 73.36M shares changing hands, 2.68M more than the previous session. This amounted to $27.88M in total market activity.
Will GOSS Continue Its Downward Trend?
According to analyst ratings and projections for GOSS, Gossamer Bio, Inc. shares are anticipated to decrease by -22.57%, potentially reaching $0.31 per share by March 10, 2026. Short-term technical indicators for GOSS currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the GOSS stock forecast, now is not the best time to buy GOSS stock because its current trading price is +102.72% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on GOSS covering social and institutional perspectives.
GOSS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GOSS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 8.30% to 19.45%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 33.68%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 41.27%, maintains a neutral outlook for the long term. Insights into GOSS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Gossamer Bio Short-Term Forecasts
GOSS Forecast For Next 5 Days
Our algorithm anticipates Gossamer Bio (GOSS) stock could hit $0.44 by Mar 04, 2026. This represents a +14.89% rise from today's price, following a +3.17% change over the past five days.
GOSS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Gossamer Bio, Inc. (GOSS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.37, which would mean a -2.66% decrease from the current price of $0.38. Projections for this period range from a high of $0.79 to a low of $0.00.
GOSS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Gossamer Bio's price over the next three months point to a rise. GOSS stock is expected to peak at $14.74 on May 20, 2026 after potentially dipping to $2.48 on Feb 26, 2026. On average, GOSS is likely to trade around $9.01 in the coming 90 days.
Gossamer Bio Stock Forecast 2025
Based on our predictive models, Gossamer Bio (GOSS) is expected to trade between $2.48 and $31.88 throughout 2026. This would result in an average price of $14.59, potentially offering investors a +3,738.46% return from current levels.
Gossamer Bio, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Gossamer Bio, Inc. (GOSS) is positioned to show a strong performance in February 2026. The price is predicted to move between $2.48 and $3.05, settling at an average of $2.76. This could translate to a +626.12% gain.
March 2026
Based on current market signals, Gossamer Bio, Inc. is projected to trend march 2026. We forecast a trading range from $3.83 to $9.89, with a likely average price of $7.72. Investors could expect a potential return of +1,931.04%.
April 2026
Our predictive algorithms indicate Gossamer Bio, Inc. stock may see a shift in April 2026. The expected range spans $6.80–$9.17, with an average target of $8.06. This represents a positive outlook and a possible gain of +2,020.49%.
May 2026
Analyzing established trends, Gossamer Bio, Inc. looks set to move in May 2026. Projections place the stock between $9.05 and $14.77, averaging around $13.00. This suggests a +3,320.15% gain from current levels.
June 2026
Market indicators suggest Gossamer Bio, Inc. could experience notable changes during June 2026. Prices could fluctuate within $11.65 to $14.50, with a midpoint forecast of $13.39. The stock might deliver a +3,422.76% gain.
July 2026
Forecasting for July 2026, models estimate that Gossamer Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.29 and $19.63, averaging $17.32. This signals a positive trajectory with potential returns around +4,456.70%.
August 2026
According to our latest forecast models, Gossamer Bio, Inc. (GOSS) is positioned to show a strong performance in August 2026. The price is predicted to move between $19.71 and $25.80, settling at an average of $21.55. This could translate to a +5,569.56% gain.
September 2026
Based on current market signals, Gossamer Bio, Inc. is projected to trend september 2026. We forecast a trading range from $22.97 to $31.88, with a likely average price of $28.50. Investors could expect a potential return of +7,398.03%.
October 2026
Our predictive algorithms indicate Gossamer Bio, Inc. stock may see a shift in October 2026. The expected range spans $13.35–$22.19, with an average target of $17.54. This represents a positive outlook and a possible gain of +4,514.58%.
November 2026
Analyzing established trends, Gossamer Bio, Inc. looks set to move in November 2026. Projections place the stock between $10.73 and $13.16, averaging around $11.94. This suggests a +3,041.28% gain from current levels.
December 2026
Market indicators suggest Gossamer Bio, Inc. could experience notable changes during December 2026. Prices could fluctuate within $5.60 to $11.11, with a midpoint forecast of $8.25. The stock might deliver a +2,070.48% gain.
January 2027
Forecasting for January 2027, models estimate that Gossamer Bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.40 and $10.28, averaging $8.92. This signals a positive trajectory with potential returns around +2,246.75%.
February 2027
According to our latest forecast models, Gossamer Bio, Inc. (GOSS) is positioned to show a strong performance in February 2027. The price is predicted to move between $8.28 and $11.48, settling at an average of $10.10. This could translate to a +2,557.20% gain.
GOSS's history of dividends and stock splits also plays a role in long-term investor confidence.